It is a hemostatic gel for temporary external use that’s designed to control moderate to severe bleeding. It is made by Cresilon in Brooklyn, New York. “Flowable as a gel, which means it gets ...

A biotechnology firm in the United States has received the Food and Drug Administration (FDA) clearance for its new innovation – a hemostatic gel that is designed to control moderate to severe ...

In emergencies, controlling the blood loss from a wound can be critical. Joe Landolina of Cresilon shares the progress being made with hemostatic gel that can stop the bleeding in seconds rather than ...

The global hemostatic gels market is on a steady growth path, with its value projected to reach USD 1.9 billion by 2032. With rising surgical procedures, increasing trauma cases, and continuous ...